The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 1,001–1,072 of 1,072
Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology
Zhang, D., Li, Z., & Li, J.-F. (2016) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.03.001 · Cited by 67
“…the bacterial type-II CRISPR/Cas adaptive immune system that is deployed by the hosts to cleave invading phage or plasmid DNA via three components (Doudna and Charpentier, 2014; Jinek et al., 2012): a protospacer-containing CRISPR RNA (crRNA), a trans-ctivating crRNA (tracrRNA) and a Cas9…”
BackgroundChalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66
Prime Editing: Genome Editing for Rare Genetic Diseases Without Double-Strand Breaks or Donor DNA
Matsoukas, I. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00528 · Cited by 65
“Since the development of CRISPR/Cas systems for genome editing (Figure 1A), the field has been subject to continuous improvements (Charpentier and Doudna, 2013; Doudna and Charpentier, 2014; Hsu et al., 2014; Sternberg and Doudna, 2015; Komor et al., 2017).”
BackgroundZinsli, L. V., Stierlin, N., Loessner, M. J., & Schmelcher, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.024 · Cited by 63
“The discovery of CRISPR-Cas9 and the possibilities that it opened for genome engineering and editing [125] was hoped to bring research closer towards personalized gene therapies for complex diseases.”
BackgroundDelivery technologies for in utero gene therapy
Palanki, R., Peranteau, W. H., & Mitchell, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.002 · Cited by 64
Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
Wagner, D. L., Peter, L., & Schmueck-Henneresse, M. (2021) · Gene Therapy · doi:10.1038/s41434-021-00232-2 · Cited by 63
“The discovery of CRISPR-Cas9 has significantly amplified the general excitement about gene therapies [19, 100].”
BackgroundLin, S.-C., Haga, K., Zeng, X.-L., & Estes, M. K. (2022) · Nature Protocols · doi:10.1038/s41596-021-00669-0 · Cited by 63
CRISPR in context: towards a socially responsible debate on embryo editing
Morrison, M., & de Saille, S. (2019) · Palgrave Communications · doi:10.1057/s41599-019-0319-5 · Cited by 62
Consumer acceptance of microalgae as a novel food‐where are we now? And how to get further
Olsen, M. L., Olsen, K., & Jensen, P. E. (2024) · Physiologia Plantarum · doi:10.1111/ppl.14337 · Cited by 62
Efficient genomic correction methods in human iPS cells using CRISPR–Cas9 system
Li, H. L., Gee, P., Ishida, K., & Hotta, A. (2016) · Methods · doi:10.1016/j.ymeth.2015.10.015 · Cited by 62
Hu, X., Li, L., Yu, X., Zhang, R., Yan, S., Zeng, Z., Shu, Y., Zhao, C., Wu, X., Lei, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22915 · Cited by 62
“The recent discovery of CRISPR/Cas9 genomeediting system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [40-44].”
BackgroundProgrammable RNA-guided DNA endonucleases are widespread in eukaryotes and their viruses
Jiang, K., Lim, J., Sgrizzi, S., Trinh, M., Kayabolen, A., Yutin, N., Bao, W., Kato, K., Koonin, E. V., Gootenberg, J. S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adk0171 · Cited by 60
“…prominent in prokaryotes including roles in innate immunity mediated by prokaryotic Argo-nautes ( 14 ), adaptive immunity by CRISPR systems ( 15 – 17 ), RNA-guided transposition by CRISPR-associated transposases ( 18 , 19 ), and still uncharacterized functions of OMEGA nucleases in transposon…”
Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR
Perales, M.-A., Kebriaei, P., Kean, L. S., & Sadelain, M. (2018) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2017.10.017 · Cited by 59
CRISPR/Cas systems: opportunities and challenges for crop breeding
Biswas, S., Zhang, D., & Shi, J. (2021) · Plant Cell Reports · doi:10.1007/s00299-021-02708-2 · Cited by 58
“Due to its high target specificity, simplicity, ease of use, CRISPR/Cas9 technique has been widely used as a dominant technique of SDNs for gene editing in crops, humans, and animals (Doudna and Charpentier 2014).”
MethodPerturbNet predicts single-cell responses to unseen chemical and genetic perturbations
Yu, H., Qian, W., Song, Y., & Welch, J. D. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00131-3 · Cited by 57
“The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology allows precise design of genetic mutants through genome editing (Doudna et al, 2014).”
Crossed wires: 3D genome misfolding in human disease
Norton, H. K., & Phillips-Cremins, J. E. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201611001 · Cited by 57
“Recent papers coupling high-resolution proximity ligation experiments (de Wit and de Laat, 2012; Dekker et al., 2013) with CRI SPR/Cas9 genome editing (Doudna and Charpentier, 2014; Hsu et al., 2014) have provided additional direct evidence for the unique role for CTCF as an architectural protein.”
Centromeric DNA Facilitates Nonconventional Yeast Genetic Engineering
Cao, M., Gao, M., Lopez-Garcia, C. L., Wu, Y., Seetharam, A. S., Severin, A. J., & Shao, Z. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00046 · Cited by 57
Getz, A. M., Ducros, M., Breillat, C., Lampin-Saint-Amaux, A., Daburon, S., François, U., Nowacka, A., Fernández-Monreal, M., Hosy, E., Lanore, F., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm5298 · Cited by 55
Hepatocyte targeting via the asialoglycoprotein receptor
Ramírez-Cortés, F., & Ménová, P. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00652f · Cited by 55
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53
Recent Progress and Challenges in CRISPR-Cas9 Engineered Algae and Cyanobacteria
Patel, V. K., Das, A., Kumari, R., & Kajla, S. (2023) · Algal Research · doi:10.1016/j.algal.2023.103068 · Cited by 50
DNA methylation in epigenetic inheritance of metabolic diseases through the male germ line
Illum, L. R. H., Bak, S. T., Lund, S., & Nielsen, A. L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0189 · Cited by 51
“However, the recent implementation of modified clustered regularly interspaced short palindromic repeat CRISPR associated protein (CRISPR-Cas9) genomic engineering tools have provided new possibilities for site-specific remodeling of the epigenome (Doudna & Charpentier 2014).”
BackgroundRNA-targeting strategies as a platform for ocular gene therapy
Kumar, S., Fry, L. E., Wang, J.-H., Martin, K. R., Hewitt, A. W., Chen, F. K., & Liu, G.-S. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101110 · Cited by 51
PCSK9 in metabolism and diseases
Ajoolabady, A., Pratico, D., Mazidi, M., Davies, I. G., Lip, G. Y. H., Seidah, N., Libby, P., Kroemer, G., & Ren, J. (2025) · Metabolism · doi:10.1016/j.metabol.2024.156064 · Cited by 49
Li, W., Zhang, Y., Han, B., Li, L., Li, M., Lu, X., Chen, C., Lu, M., Zhang, Y., Jia, X., et al. (2019) · eLife · doi:10.7554/elife.48081 · Cited by 49
“Introduction Targeted genome modifications via customizable endonucleases such as TALENs or the CRISPR/Cas system have revolutionized the technology of genome editing, through which gene knockouts can be easily generated through nonhomologous end joining (NHEJ)-induced indel mutations in many species, including zebraf…”
BackgroundKotagama, O. W., Jayasinghe, C. D., & Abeysinghe, T. (2019) · BioMed Research International · doi:10.1155/2019/1369682 · Cited by 48
“Extensive work was subsequently put into pioneering a technique of genome editing that was rapid and precise by Doudna and Charpentier using these findings which resulted in the creation of the CRISPR/Cas9 tool [6].”
BackgroundMethodGao, Z., Harwig, A., Berkhout, B., & Herrera-Carrillo, E. (2017) · Transcription · doi:10.1080/21541264.2017.1322170 · Cited by 47
CRISPR-Cas systems in multicellular cyanobacteria
Hou, S., Brenes-Álvarez, M., Reimann, V., Alkhnbashi, O. S., Backofen, R., Muro-Pastor, A. M., & Hess, W. R. (2019) · RNA Biology · doi:10.1080/15476286.2018.1493330 · Cited by 47
Amann, T., Schmieder, V., Faustrup Kildegaard, H., Borth, N., & Andersen, M. R. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27101 · Cited by 46
“First genome editing experiments using ZFN were performed from 1996-2003 with an expanded application of ZFNs onwards, whereas TALENs entered the cell line engineering area in 2009/2010 only (Bibikova, Beumer, Trautman & Carroll, 2003; Boch et al., 2009; Doudna & Charpentier, 2014).”
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis
Mou, H., Moore, J., Malonia, S. K., Li, Y., Ozata, D. M., Hough, S., Song, C.-Q., Smith, J. L., Fischer, A., Weng, Z., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620861114 · Cited by 46
Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
Leonard, A., Tisdale, J., & Abraham, A. (2020) · British Journal of Haematology · doi:10.1111/bjh.16437 · Cited by 45
“…of clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9), however, has revolutionized genome editing strategies, introducing a methodology that is easy to design, highly efficient, and inexpensive (Doudna & Charpentier, 2014; Sternberg et al., 2014).”
CRISPR in Animals and Animal Models
Shrock, E., & Güell, M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.07.010 · Cited by 45
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
Umeyama, T., Hayashi, Y., Shimosaka, H., Inukai, T., Yamagoe, S., Takatsuka, S., Hoshino, Y., Nagi, M., Nakamura, S., Kamei, K., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00894-18 · Cited by 43
“Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 has been applied as a powerful genome editing tool in various organisms (5).”
BackgroundMethodInfluentialSchleidgen, S., Dederer, H.-G., Sgodda, S., Cravcisin, S., Lüneburg, L., Cantz, T., & Heinemann, T. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00487-1 · Cited by 43
Contreras-Salgado, E. A., Sánchez-Morán, A. G., Rodríguez-Preciado, S. Y., Sifuentes-Franco, S., Rodríguez-Rodríguez, R., Macías-Barragán, J., & Díaz-Zaragoza, M. (2024) · Microbiology Research · doi:10.3390/microbiolres15030113 · Cited by 42
Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
TCW, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.043 · Cited by 39
Interphotoreceptor Retinoid-Binding Protein (IRBP) in Retinal Health and Disease
Zeng, S., Zhang, T., Madigan, M. C., Fernando, N., Aggio-Bruce, R., Zhou, F., Pierce, M., Chen, Y., Huang, L., Natoli, R., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.577935 · Cited by 37
“Since the development of gene-editing techniques such as zincfinger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), the third generation, clustered regularly interspaced short palindromic repeats (CRISPR) technique has recently risen (Doudna and Charpentier, 2014).”
BackgroundShen, Q., Ruan, H., Zhang, H., Wu, T., Zhu, K., Han, W., Dong, R., Ming, T., Qi, H., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1375120 · Cited by 38
“There is no denying the fact that CRISPR-Cas systems, which introduce DSB for gene editing at target genes, may have a negative impact on genome stability (Doudna and Charpentier, 2014).”
BackgroundCellular cartography: Towards an atlas of the neuronal microtubule cytoskeleton
Iwanski, M. K., & Kapitein, L. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1052245 · Cited by 38
Salman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection
Xue, Y., Wang, C., Li, H., Du, S., Zhong, Y., Zhang, Y., Wang, S., Guo, K., Hou, X., Kang, D. D., et al. (2025) · Advanced Materials · doi:10.1002/adma.202417097 · Cited by 34
Quick, R. E., Buck, L. D., Parab, S., Tolbert, Z. R., & Matsuoka, R. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735598 · Cited by 32
“A Mechanism Underlying Highly Efficient Biallelic Inactivation After Triple dgRNP Injections CRISPR/Cas9-induced DNA double-strand break repair via nonhomologous end-joining can result in insertions/deletions of unpredictable length and install a premature termination codon (PTC; Ran et al., 2013; Doudna and Charpenti…”
BackgroundMollanoori, H., Rahmati, Y., Hassani, B., Havasi Mehr, M., & Teimourian, S. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2019.12.007 · Cited by 32
Anti‐CRISPR proteins targeting the CRISPR‐Cas system enrich the toolkit for genetic engineering
Liu, Q., Zhang, H., & Huang, X. (2020) · The FEBS Journal · doi:10.1111/febs.15139 · Cited by 31
Pitt, C., Paschen, J., Kietzmann, J., Pitt, L. F., & Pala, E. (2023) · Australasian Marketing Journal · doi:10.1177/18393349211044175 · Cited by 30
“A good recent example of this concerns what is arguably the single most significant technological advance of the 21st century to date, CRISPR (“clusters of regularly interspaced short palindromic repeats”) (see Doudna & Charpentier, 2014; Jinek et al., 2012).”
BackgroundCandida glabrata : new tools and technologies—expanding the toolkit
Ho, H.-L., & Haynes, K. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov066 · Cited by 29
“specific mutations (Mali, Esvelt and Church 2013; Doudna and Charpentier 2014; Gilles and Averof 2014; Kim and Kim 2014; Sander and Joung 2014), it is probable that using the CRISPR-Cas9”
BackgroundInfluentialCRISPR/Cas9-Mediated Integration of Large Transgene into Pig CEP112 Locus
Li, G., Zhang, X., Wang, H., Mo, J., Zhong, C., Shi, J., Zhou, R., Li, Z., Yang, H., Wu, Z., et al. (2020) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.119.400810 · Cited by 29
“…activator-like effectornucleases, andclustered regularly interspacedshortpalindromic repeats (CRISPR)-associated protein 9 (Cas9) system can enable the targeted generation of DNA double strand breaks (DSBs) with high accuracy and efficiency (Doudna and Charpentier 2014; Hsu et al. 2014).”
BackgroundHu, G.-R., Fan, Y., Zheng, Y.-L., Xu, F., Zhang, L., & Li, F.-L. (2020) · Journal of Applied Phycology · doi:10.1007/s10811-019-01969-5 · Cited by 27
“In addition, the mutants created by CRISPR/Cas9 are more genetically stable than those through insertional DNA or RNAi methods.”
BackgroundInfluentialPreservation and Encryption in DNA Digital Data Storage
Zhang, Y., Ren, Y., Liu, Y., Wang, F., Zhang, H., & Liu, K. (2022) · ChemPlusChem · doi:10.1002/cplu.202200183 · Cited by 28
Nanoblades allow high-level genome editing in murine and human organoids
Tiroille, V., Krug, A., Bokobza, E., Kahi, M., Bulcaen, M., Ensinck, M. M., Geurts, M. H., Hendriks, D., Vermeulen, F., Larbret, F., et al. (2023) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2023.06.004 · Cited by 25
“Gene editing consists in manipulating the genome to induce gene silencing, gene modification, or transgene integration at a precise locus.(16) In contrast to ectopic DNA sequence insertion using integrative vectors, genome editing allows more physiological gene manipulation.”
BackgroundPerturbNet predicts single-cell responses to unseen chemical and genetic perturbations
Yu, H., & Welch, J. D. (2022) · doi:10.1101/2022.07.20.500854 · Cited by 57
“The Clustered Regu37 larly Interspaced Short Palindromic Repeats (CRISPR) technology allows precise design of genetic 38 mutants through genome editing [3].”
BackgroundYaish, O., Asif, M., & Orenstein, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac157 · Cited by 19
Evasion of Pre-Existing Immunity to Cas9: A Prerequisite for Successful Genome Editing In Vivo?
Wignakumar, T., & Fairchild, P. J. (2019) · Current Transplantation Reports · doi:10.1007/s40472-019-00237-2 · Cited by 19
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases
Xu, C. L., Cho, G. Y., Sengillo, J. D., Park, K. S., Mahajan, V. B., & Tsang, S. H. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00046 · Cited by 19
“The CRISPR genome surgery tool is able to edit, delete, insert, activate, repress, epigenetically modify, and induce directed evolution (Doudna and Charpentier, 2014; Hess et al., 2016; Cabral et al., 2017).”
BackgroundWang, Y., Tian, Y., Xu, D., Cheng, S., Li, W.-W., & Song, H. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108516 · Cited by 17
Olney, N. T., Alquezar, C., Ramos, E. M., Nana, A. L., Fong, J. C., Karydas, A. M., Taylor, J. B., Stephens, M. L., Argouarch, A. R., Van Berlo, V. A., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1764-0 · Cited by 15
Malbranke, C., Rostain, W., Depardieu, F., Cocco, S., Monasson, R., & Bikard, D. (2023) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1011621 · Cited by 15
“The Cas9 protein is an RNA guided nuclease from the prokaryotic immune system known as CRISPR-Cas9 [32].”
BackgroundA genetically tractable non-vertebrate system to study complete camera-type eye regeneration
Accorsi, A., Pardo, B., Ross, E., Corbin, T. J., McClain, M., Weaver, K., Delventhal, K., Gattamraju, A., Morrison, J. A., McKinney, M. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61681-6 · Cited by 14
A new genetically tractable non-vertebrate system to study complete camera-type eye regeneration
Accorsi, A., Pardo, B., Ross, E., Corbin, T. J., McClain, M., Weaver, K., Delventhal, K., Morrison, J. A., McKinney, M. C., McKinney, S. A., et al. (2024) · doi:10.1101/2024.01.26.577494 · Cited by 14
CRISPR-Cas mediated genome engineering of cyanobacteria
Sengupta, A., Liu, D., & Pakrasi, H. B. (2022) · Methods in Enzymology · doi:10.1016/bs.mie.2022.07.023 · Cited by 13
Chromatin structure and context-dependent sequence features control prime editing efficiency
Kim, S., Yuan, J. B., Woods, W. S., Newton, D. A., Perez-Pinera, P., & Song, J. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1222112 · Cited by 12
Genome Editing for the β-Hemoglobinopathies
Porteus, M. H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-7299-9_8 · Cited by 8
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
SNM1A is crucial for efficient repair of complex DNA breaks in human cells
Swift, L. P., Lagerholm, B. C., Henderson, L. R., Ratnaweera, M., Baddock, H. T., Sengerova, B., Lee, S., Cruz-Migoni, A., Waithe, D., Renz, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49583-5 · Cited by 6
“CRISPR-Cas9 genome editing was performed using sgRNAs designed using an in-house design tool.”
InfluentialThe CRISPR/Cas9 System for Crop Improvement: Progress and Prospects
Leong, K.-Y. B., Chan, Y.-H., Abdullah, W. M. A. N. W., Lim, S.-H. E., & Lai, K.-S. (2018) · Next Generation Plant Breeding · doi:10.5772/intechopen.75024 · Cited by 5
A single viral enzyme drives tRNA-dependent hypermodification of DNA at adenine
Silva, R. M. B., Slyvka, A., Lee, Y.-J., Guan, C., Lund, S. R., Raleigh, E. A., Skowronek, K., Kuska, M. S., Bochtler, M., & Weigele, P. R. (2026) · Nature Communications · doi:10.1038/s41467-026-70671-1 · Cited by 3
“9 and 14). tRNA Gly/GCC -CC-2 ′ -dA was generated by IVT and CCA2 addition of 2 ′ - dA from 2 ′ -dATP.”
Manghwar, H., Li, B., Ding, X., Hussain, A., Lindsey, K., Zhang, X., & Jin, S. (2020) · Advanced Science · doi:10.1002/advs.201902312 · Cited by 347
Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1
Yamano, T., Zetsche, B., Ishitani, R., Zhang, F., Nishimasu, H., & Nureki, O. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.035 · Cited by 322
“…CRISPR-Cas (clustered regularly interspaced short palindromic repeatCRISPR-associated) adaptive immune system helps bacteria and archaea defend themselves against the invasion of foreign nucleic acids (Doudna and Charpentier, 2014; Marraffini, 2015; Mohanraju et al., 2016; Wright et al., 2016).”
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Behr, M., Zhou, J., Xu, B., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.020 · Cited by 210
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
Morisaka, H., Yoshimi, K., Okuzaki, Y., Gee, P., Kunihiro, Y., Sonpho, E., Xu, H., Sasakawa, N., Naito, Y., Nakada, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13226-x · Cited by 198
“However, several important challenges for the CRISPR-Cas3 system remain: (1) overall it has a lower editing efficiency compared with the CRISPR-Cas9 system; (2) it is difficult to deliver multi-effector components to cells or tissues; and (3) there are concerns about the immunogenicity of several bacterial proteins.”
BackgroundLiu, Z., Chen, S., Jin, X., Wang, Q., Yang, K., Li, C., Xiao, Q., Hou, P., Liu, S., Wu, S., et al. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0174-2 · Cited by 131
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.